Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Dana-Farber Cancer Institute patents EP300 degraders

May 28, 2020

TGF-beta receptor type-1 inhibitors discovered at Medshine Discovery

May 28, 2020

Gilead identifies new MAP4K1 inhibitors

May 28, 2020

Dana-Farber Cancer Institute presents new JAK2 inhibitors

May 27, 2020

New Mcl-1 inhibitors disclosed by Prelude Therapeutics

May 27, 2020

Chi-Med and BeiGene to study surufatinib and fruquintinib with tislelizumab for solid tumors

May 26, 2020

PEG10 found behind pathogenic mechanisms of mycosis fungoides

May 26, 2020

Germline ApoE variants affect melanoma trajectory

May 26, 2020

New SSAO inhibitors identified at Boehringer Ingelheim

May 26, 2020

Karus Therapeutics initiates phase II study of KA-2507 in biliary tract cancer

May 26, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...